Comparison between Nectar Lifesciences IPO and Syndicate Bank FPO.
Nectar Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Syndicate Bank FPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Nectar Lifesciences IPO is up to ₹92.88 Cr whereas the issue size of the Syndicate Bank FPO is up to ₹250.00 Cr. The final issue price of Nectar Lifesciences IPO is ₹240.00 per share and of Syndicate Bank FPO is ₹50.00 per share.
| Nectar Lifesciences IPO | Syndicate Bank FPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹200.00 per share | ₹46.00 per share |
| Issue Price (Upper) | ₹240.00 per share | ₹50.00 per share |
| Issue Price (Final) | ₹240.00 per share | ₹50.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 38,70,000 shares | 5,00,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹92.88 Cr | up to ₹250.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,70,000 shares | 5,00,00,000 shares |
| Issue Size Total (Amount) | up to ₹92.88 Cr | up to ₹250.00 Cr |
Nectar Lifesciences IPO opens on Jun 22, 2005, while Syndicate Bank FPO opens on Jul 07, 2005. The closing date of Nectar Lifesciences IPO and Syndicate Bank FPO is Jun 28, 2005, and Jul 13, 2005, respectively.
Nectar Lifesciences IPO P/E ratio is , as compared to Syndicate Bank FPO P/E ratio of .
| Nectar Lifesciences IPO | Syndicate Bank FPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.08 | 73.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.93 | 66.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 31.3 | 25.79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Nectar Lifesciences IPO Retail Individual Investors (RII) are offered 13,54,500 shares while in Syndicate Bank FPO retail investors are offered 13,54,500 shares. Qualified Institutional Buyers (QIB) are offered 19,35,000 shares in Nectar Lifesciences IPO and 2,25,00,000 shares in Syndicate Bank FPO.
| Nectar Lifesciences IPO | Syndicate Bank FPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 19,35,000 shares | 2,25,00,000 shares |
| NII | 5,80,500 shares | 67,50,000 shares |
| RII | 13,54,500 shares | 1,57,50,000 shares |
| Employee | 0 shares | 50,00,000 shares |
| Others | ||
| Total | 38,70,000 shares | 5,00,00,000 shares |
Nectar Lifesciences IPO subscribed in total, whereas Syndicate Bank FPO subscribed .
